Il y a eu 50 transactions d'initiés récentes enregistrées pour Catalent, Inc. (CTLT), dont 18 achats et 32 ventes. Le total des achats d'initiés s'élève à RSU Award et le total des ventes d'initiés à $11.65M.
Les initiés notables ayant une activité récente comprennent Stahl Jack L, Classon Rolf A, Damelio Frank A. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — CTLT
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2024-12-18 |
Stahl Jack L |
Director |
Restitution d'Actions |
47,984 |
- |
- |
- |
| 2024-12-18 |
Classon Rolf A |
Director |
Restitution d'Actions |
47,984 |
- |
- |
- |
| 2024-12-18 |
Damelio Frank A |
Director |
Restitution d'Actions |
12,635 |
- |
- |
- |
| 2024-12-18 |
Morel Donald E Jr |
Director |
Restitution d'Actions |
70,118 |
- |
- |
- |
| 2024-12-18 |
Lucier Gregory T |
Director |
Restitution d'Actions |
36,914 |
- |
- |
- |
| 2024-12-18 |
Greisch John J |
Executive Chair |
Restitution d'Actions |
127,096 |
$48.98 |
$6.23M |
- |
| 2024-12-18 |
Carroll J Martin |
Director |
Restitution d'Actions |
32,734 |
- |
- |
- |
| 2024-12-18 |
Masanovich Matti |
SVP, Chief Financial Officer |
Restitution d'Actions |
81,082 |
$44.76 |
$3.63M |
- |
| 2024-12-18 |
Gennadios Aristippos |
Group Pres. Pharma & Consumer |
Restitution d'Actions |
21,562 |
- |
- |
- |
| 2024-12-18 |
Evoli Lisa |
SVP, Chief HR Officer |
Restitution d'Actions |
12,032 |
- |
- |
- |
| 2024-12-18 |
Maselli Alessandro |
President & CEO |
Restitution d'Actions |
113,224 |
- |
- |
- |
| 2024-12-18 |
Gunther Scott |
SVP, Quality & Reg. Affairs |
Restitution d'Actions |
12,938 |
- |
- |
- |
| 2024-12-18 |
Ferraro Joseph Anthony |
SVP, General Counsel, Cco |
Restitution d'Actions |
14,265 |
- |
- |
- |
| 2024-12-18 |
Okey Stephanie |
Director |
Restitution d'Actions |
12,635 |
- |
- |
- |
| 2024-12-18 |
Hatzfeld Michael |
Chief Accounting Officer |
Restitution d'Actions |
3,144 |
- |
- |
- |
| 2024-12-18 |
Barg Steven |
Director |
Restitution d'Actions |
12,374 |
- |
- |
- |
| 2024-12-18 |
Barber Michael J |
Director |
Restitution d'Actions |
18,052 |
- |
- |
- |
| 2024-12-18 |
Hopson Ricky |
Pres. Bioproduct Delivery, Cos |
Restitution d'Actions |
10,669 |
$46.51 |
$496.22K |
- |
| 2024-12-18 |
Ryan Michelle R |
Director |
Restitution d'Actions |
10,835 |
- |
- |
- |
| 2024-12-18 |
Mcerlane David |
Group President, Biologics |
Restitution d'Actions |
11,426 |
- |
- |
- |
| 2024-11-11 |
Ryan Michelle R |
Director |
Vente Informative |
2,800 |
$59.70 |
$167.16K |
10,835 |
| 2024-10-30 |
Stahl Jack L |
Director |
Attribution de RSU |
4,663 |
- |
- |
47,984 |
| 2024-10-30 |
Classon Rolf A |
Director |
Attribution de RSU |
4,663 |
- |
- |
47,984 |
| 2024-10-30 |
Damelio Frank A |
Director |
Attribution de RSU |
4,663 |
- |
- |
12,635 |
| 2024-10-30 |
Morel Donald E Jr |
Director |
Attribution de RSU |
4,663 |
- |
- |
70,118 |
| 2024-10-30 |
Lucier Gregory T |
Director |
Attribution de RSU |
4,663 |
- |
- |
36,914 |
| 2024-10-30 |
Carroll J Martin |
Director |
Attribution de RSU |
4,663 |
- |
- |
32,734 |
| 2024-10-30 |
Okey Stephanie |
Director |
Attribution de RSU |
4,663 |
- |
- |
12,635 |
| 2024-10-30 |
Barg Steven |
Director |
Attribution de RSU |
4,663 |
- |
- |
12,374 |
| 2024-10-30 |
Barber Michael J |
Director |
Attribution de RSU |
4,663 |
- |
- |
18,052 |
| 2024-10-30 |
Ryan Michelle R |
Director |
Attribution de RSU |
4,663 |
- |
- |
13,635 |
| 2024-10-18 |
Ferraro Joseph Anthony |
SVP, General Counsel, Cco |
Vente Informative |
320 |
$59.97 |
$19.19K |
23,967 |
| 2024-09-26 |
Mcerlane David |
Group President, Biologics |
Vente Informative |
1,994 |
$59.97 |
$119.58K |
36,304 |
| 2024-08-02 |
Gennadios Aristippos |
Group Pres. Pharma & Consumer |
Vente Informative |
1,169 |
$59.55 |
$69.61K |
113,724 |
| 2024-08-02 |
Evoli Lisa |
SVP, Chief HR Officer |
Vente Informative |
3,859 |
$59.67 |
$230.27K |
39,366 |
| 2024-08-02 |
Gunther Scott |
SVP, Quality & Reg. Affairs |
Vente Informative |
666 |
$59.55 |
$39.66K |
39,635 |
| 2024-08-02 |
Ferraro Joseph Anthony |
SVP, General Counsel, Cco |
Vente Informative |
608 |
$59.58 |
$36.22K |
24,287 |
| 2024-08-02 |
Hopson Ricky |
Pres. Bioproduct Delivery, Cos |
Vente Informative |
662 |
$59.56 |
$39.43K |
29,974 |
| 2024-07-29 |
Gennadios Aristippos |
Group Pres. Pharma & Consumer |
Vente Informative |
349 |
$58.70 |
$20.49K |
114,893 |
| 2024-07-29 |
Maselli Alessandro |
President & CEO |
Vente Informative |
9,088 |
$58.76 |
$534.01K |
177,521 |
| 2024-07-29 |
Gunther Scott |
SVP, Quality & Reg. Affairs |
Vente Informative |
283 |
$58.69 |
$16.61K |
40,301 |
| 2024-07-29 |
Hopson Ricky |
Pres. Bioproduct Delivery, Cos |
Vente Informative |
206 |
$58.67 |
$12.09K |
30,636 |
| 2024-07-26 |
Greisch John J |
Executive Chair |
Attribution de RSU |
63,736 |
- |
- |
79,932 |
| 2024-07-26 |
Masanovich Matti |
SVP, Chief Financial Officer |
Attribution de RSU |
42,604 |
- |
- |
76,475 |
| 2024-07-26 |
Gennadios Aristippos |
Group Pres. Pharma & Consumer |
Attribution de RSU |
18,746 |
- |
- |
115,242 |
| 2024-07-26 |
Evoli Lisa |
SVP, Chief HR Officer |
Attribution de RSU |
15,338 |
- |
- |
43,225 |
| 2024-07-26 |
Maselli Alessandro |
President & CEO |
Attribution de RSU |
98,671 |
- |
- |
186,609 |
| 2024-07-26 |
Gunther Scott |
SVP, Quality & Reg. Affairs |
Attribution de RSU |
11,078 |
- |
- |
40,584 |
| 2024-07-26 |
Ferraro Joseph Anthony |
SVP, General Counsel, Cco |
Attribution de RSU |
17,042 |
- |
- |
24,895 |
| 2024-07-26 |
Hatzfeld Michael |
Chief Accounting Officer |
Attribution de RSU |
5,624 |
- |
- |
13,532 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
